Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

This study has been completed.
Sponsor:
Collaborators:
Universidad del Valle, Guatemala
University of Alabama at Birmingham
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00127504
First received: August 4, 2005
Last updated: August 23, 2005
Last verified: August 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2004
  Estimated Primary Completion Date: No date given